SlideShare a Scribd company logo
The Biocidal Product Regula-
tion (BPR, Regulation (EU)
528/2012) came into force on
1 September 2013 (repealing
the Biocidal Products Directi-
ve (Directive 98/8/EC)). The
BPR concerns the placment
and use of biocidal products
on the market, which are used
to protect humans, animals,
materials or articles against
harmful organisms, like pests
or bacteria through active
substances within the biocidal
product.
In general, all biocidal pro-
ducts require authorization
before they can be placed on
the market, and the active
substances contained in that
biocidal product must be
previously approved. How-
ever, there are certain excepti-
ons and transitional periods
for certain provisions. For
example, active substances in
the Review Programme
(where the final decision on
approval is still pending) can
be made available on the mar-
ket as ingredient in biocidal
products. Products contai-
ning new active substances
that are still under assessment
may also be allowed on the
market if provisional authori-
sation is granted.
Applications for active sub-
stances or biocidal products
are done on the IT tool IU-
CLID 5 (International Uni-
form Chemical Information
Database). The application
dossiers will be submitted to
ECHA via the IT platform
R4BP 3 (Register for Biocidal
Products). This tool is also
used to exchange data and
information between the ap-
plicant, ECHA, Member State
competent authorities and the
European Commission which
grant authorization.
This guide is meant to intro-
duce the interested party to
the processes involved in a
biocidal product application.
It is important to note that
biocidal products typically
takes at least two years to fully
authorize as there are two
steps primary involved (the
authorization of the active
substances in the product
then the authorization of the
biocidal product). With the
current EU policy requiring
all biocides to be registered by
September 2015, now is the
time to begin the application
process in order to complete-
ly and correctly submit your
application. If your applica-
tion is not submitted in time,
the biocidal product will
have to be pulled from the
market regardless of whether
it is safe or not.
MAY 2015
Introduction
Version 1.0
GeneralGuideforBiocidalAuthorization
ACA-PHARMACONCEPTGMBH
Biocide Definition
Introduction 1
Biocide Definition 1
Active Substance 2
Application Timeline 2
Special Deadlines 2
List of Abreviations 3
SME Status 3
Product Types 4
Authorization Types 5
Nanomaterials 5
In situ Biocides 5
List of Other Guides 6
Useful Links 6
Contact Information 6
Table of Contents
According to Article 3 of BPR,
a biocide is any substance or
mixture, in the form in which
it is supplied to the user, con-
sisting of, containing or gene-
rating one or more active sub-
stances, with the intention of
destroying, deterring, ren-
dering harmless, preventing
the action of, or otherwise
exerting a controlling effect on
any harmful organism by any
means other than mere physi-
cal or mechanical action as
well as any substance or mix-
ture, generated from sub-
stances or mixtures which do
not themselves fall under the
first definition, to be used with
the intention of destroying,
deterring, rendering harmless,
preventing the action of, or
otherwise exerting a control-
ling effect on, any harmful
organism by any means
other than mere physical or
mechanical action.
Often biocides are used to
protect economic products
that could be damaged or
destroyed by a harmful orga-
nism. This includes argicul-
tural products including
food and lumber as well as
animals. Generally speaking,
biocides under this definiti-
on are either pesticides
(including herbicides,
insceticides, and rodentici-
des among others) or anti-
microbials (including antibi-
otics, antifugals, and antipa-
rasites among others) or
both. It is important to no-
te, however, that a product
will only be considered a
biocide if its action does not
fall into the list of regulati-
ons in Article 2 of BPR
which includes biocides that
are present in feed, medica-
ted feedstuffs,veterinary
medicines,human medicines,
flavourings and ingredients
with flavouring properties,
plant protection products,
toys, cosmetics, or biocides
used as processing aids.
by ECHA before entering the market.
In situ biocides must submit their dossiers
which include the suppliers of the precur-
sors as well as information on the biocide
produced to ECHA for evaluation by the
1st of September 2015.
Articles treated with biocides must have
submitted their applications by the 1st of
September 2016 unless it contains ative
substances that have not been yet recogn-
zed by ECHA in which case it has until
March 1st 2017.
Biocidal products with SVHCs/candidates
for substitution as active substances or
non-active components must be regis-
tered by September 1st 2015 and since
ECHA is attempting to replace SVHCs,
these products cannot be authorized for
more than five years.
Seite 2 GENERAL GUIDE FOR BIOCIDAL AUTHORIZATION
Application Timeline
Submission
of Application
Validation
For substances currently
on the market, submissi-
on must occur by the:
1st of September 2015
Fee
payment
Requested
information
BPC
decision
30 30 90 365 270 days
Comments
on draft
30Dossier
evaluation
Committee
decision for
authorization
The time for authorization of a biocidal product is approximately two years. The time required for
a dossier evaluation and BPC decision are approximate. The time required for the final committee
decision on authorization is highly variable. Also, should additional information be requested
during the dossier evaluation, an additional 180 days may be given to provide the necessary data.
Biocidal authorization can be granted
for up to 10 years. If the biocidal pro-
duct contains a substance that is up for
substitution, the biocidal product can-
not get granted authorization for more
than 5 years.
If the substance in question is already
under the jurisdiction of a previous
biocidal regulation, it does not have to
follow current ECHA biocidal regulati-
ons. Materials which wish to enter the
European market must be approved
Special Deadlines
Additional
information
180
EU
authorization
Before any biocidal product is approved by ECHA, the active substances that are part of a biocidal function must be ap-
proved and authorized for use in the EU through ECHA.
The first step to do this is to submit a IUCLID active substance portfolio to a member state‘s competenet authority via
R4BP3. After the member state has evaluated the substance, ECHA‘s biocidal comittee will also decide on the status of
the active substance in question within 270 days. [For further information on how to use and submit the required informa-
tion to ECHA for approval, please see ACA-Pharma Concept‘s IUCLID guide to Biocides]
These opinions serve as the basis for the decision on approval which is then adopted by the European Commission. Gai-
ning approval for the active substance can take well over a year, so it is important to start the approval process as soon as
possible. Once approval has been granted, an active substance‘s approval can be granted for up to 10 years and is rewable.
In principle, active substances meeting the exclusion criteria defined in the BPR will not be approved. However, sub-
stances of very high concern, such as those that are carcinogenic, mutagenic and reprotoxic substances in categories 1A
or 1B in CLP Regulation, endocrine disruptors, and substances which are persistent bioaccumulative and toxic (PBT) or
are very persistent and very bioacumulative (vPvB) will not be approved unless there are no alternatives available. If the
substance of high concern is indeed the only option, it can only be approved for up to five years and is subject to evaulati-
on in the case of a better, safer substitute.
Biocidal Products Committee opinions on active substance approval can be viewed on ECHA Homepage. European
Commission includes approved active substances in the Union list of approved active substances (formerly Annex I of
Directive 98/8/EC). Companies wishing to get an authorisation for a biocidal product can consult this list to identify ac-
tive substances for use in biocidal products and treated articles.
A consolidated list of existing active substances for which a decision of non-inclusion into Annex I or IA of Directive
98/8/EC has been adopted is also available. Biocidal products containing active substances for which a non-inclusion
decision was taken shall be removed from the market within 12 months of the entering into force of such decision; unless
otherwise stipulated in that non-inclusion decision.
Active Substance Authorization
List of Abbreviations
Abbreviation Complete name Explanation
BPC Biocidal product committee The committe under ECHA which ultimately decides the fate of a dossier‘s applicaiton (whether
or not is should be authorized)
BPR Biocidal product regiulation Regulation EC 528/2012 that governs the use, productions, and distribution of biocides in the
EU which companies are obligated to follow
CLP Classification, labelling and packaging
regulation
Regulation EC 1272/2008 that harmonizes the criteria for classification and the rules on label-
ling and packaging harardous goods and mixtures
ECHA European Chemicals Agency Regulatory authority on chemical safety which is also responsible for the impelentation of EU
chemical regulations
EU European Union International governing body which allows for trade and economic regualtions to be the same
throughout member states
IUCLID International Uniform Chemical
Information Database
IT tool used for data submission, evaluation and exchange
PBT Persistent bioaccumulative and toxic A variety of toxic chemicals that exhibit persistent bioacculumative properties that are consi-
dered SVHCs by ECHA
REACH Registration, evaluation, authorization ,
and restriction of chemicals
Regulation EG 1907/2006 which stipulates the registration, evaluation, authorization, and
restriction processes and rules for chemicals in the EU
SME Micro-, small, and medium-sized enter-
prises
Enterprises that are defined according to their staff head count and turnover or annual balan-
ce-sheet total. Thez can recieve discounted fees and charges during ECHA registration once
their SME status is confirmed
SVHC Substance of very high concern Substances meeting the criteria for classification as carcinogenic, mutagenic or toxic for repro-
duction category 1A or 1B or which are PBT or vPvB or giving rise to an equivalent level of
concern. They may need to be authorised for specific uses but must follow stricter guidelines
as approved by ECHA
vPvB Very persistent and very bioaccumulati-
ve
A variety of chemicals that are very bioacculumative and persist in the environment for pro-
longed periods of time that are considered SVHCs by ECHA
Seite 3MAY 2015
SME Status
SMEs (micro-,small, and medium enter-
prises) are elligible for reduced fees and
charges during ECHA registration. As
such, SME registration is highly moni-
tored and mistakes within the applicati-
on for SME status can result in steep
fine and charges.
The information needed to prove SME
status is simple: staff head count and
annual turnover/balance sheet totals.
Of these two factors, staff head count is
the more important of the two and will
often decide the exact status of the
enterprise. Staff, in this case, applies to
employees (actual or recognized as usch
under national law), owner-managers,
persons working for the enterprise and
being subordinated to it, as well as part-
ners who are engaged in the company and
recieve financial benefits from it. It does
not include apprentices or students enga-
ged in vocational training. Maternity and
paternity leaves are also not included.
Microenterprises should have a staff of
less than 10 individuals. Small enterprises
should have less than 50 staf members
while medium enterprises should have less
than 250. If the staff number falls below a
threshold, the annual turnover/annual
balanace sheet total for the past two years
will be used to determine placement.
Microenterprises should have an annual
turnover less than 2 million euros while a
small enterprise and a medium enterprise
should have annual turnovers of less than
10 million euros and 43 million euros
respectively.
It is important to note that if the enter-
prise in question is not autonomous (fully
independent or lesss than 25% of its ca-
pital or holding rights are held by outside
investors) all of its linked or partner
enterprises must be included in the deter-
mination of SME status.
Seite 4 GENERAL GUIDE FOR BIOCIDAL AUTHORIZATION
Product Types
Main Group Type
number
Product-type Description
Disinfectants 1 Human hygiene products Skin or scalp disinfectants
Disinfectants 2 Disinfectants/algaecides not for dirrect
applications to humans or animals
Surface disinfectants, water disinfecants that are not intended for animal or human
ingestion, air disiinfectants, and other products with disinfecting properties...
Disinfectants 3 Veterinary hygiene Surface disinfectants and anti-microbials for the housing of animals...
Disinfectants 4 Food and feed area Disinfectants for equipment, containers, utensils, surfaces, or pipework associated
with production, storage, transport, or consumption of food and feed including water
Disinfectants 5 Drinking water disinfectants For animals and human use
Preservatives 6 Preservatives for products during
storage
Preservation of manufactured products other than foodtuffs, feedingstuffs, cometics,
or medical products and storage or use of rodenticide, insecticide, or other baits
Preservatives 7 Film preservatives Preservation of paints, plastics, selanats, sealants, binders, papers, art work, and wall
adhesives
Preservatives 8 Wood preservatives Preventative and curative products from and including the saw-mill stage
Preservatives 9 Fiber, leather, rubber, and polymerized
material preservatives
Materials which prevent microbial settling and deterioration
Preservatives 10 Construction material preservatives Preservation of masonry, composiste materials and other non-wood materials
Preservatives 11 Preservatives for liquid-cooling an
dprocessing systems
Preservation of water and other liquids by controlling organisms
Preservatives 12 Slimicides Prevention/control of slime on materials, equipment and structures in industrial pro-
cesses
Preservatives 13 Working or cutting fluid preservatives Control microbial deteioration in fluids used for working or cutting metals, glass, or
other materials
Pesticides 14 Rodenticides By means other than repulsion or attraction
Pesticides 15 Avicides By means other than repulsion or attraction
Pesticides 16 Molluscicides vermicides, and products
used to control other invertebrates
By means other than repulsion or attraction
Pesticides 17 Piscicides By means other than repulsion or attraction
Pesticides 18 Insceticides, acaracides, and products
to control other arthropods
By means other than repulsion or attraction
Pesticides 19 Repellents and attractants By repelling or attracting harmful organisms (including fleas, vertebrates such as
birds, fish and rodents) in question on a surface or on human or animal skin
Pesticides 20 Control of other vertebrates Other methods of control other than attraction or repulsion of vertebrates other than
those before
Other Biocidal
Product
21 Antifouling products Limit the settling of microbes and higher organisms on vessels, aquaculture or other
structures in water
Other Biocidal
Product
22 Embalming or taxidermist fluids Disinfection and preservation of human and animal corpses
Authorization Types
Seite 5MAY 2015
ECHA provides several kinds of authorization types for biocidal products The determination of which authorization is given de-
pends on the product in question as well as the markets(s) in which the company wants to sell its product in.
National authorization
National authorization is for companies that want their product to be authorized in one EU member state. The application
must be submitted via R4BP 3. The member state‘s competent authority will then process the authorization request analyze
and compare the substance to other substances which may be less harmful, and make a decision on authorization within
365 days.
Mutual recognition
Mutual recognition is national authorization that has been recognized beyong the frist/reference country of application and
is done when a company requests other EU member states to recognize ist product.This can be done in parallel or sequen-
tially with its application to the reference EU member state. Either way, the dossier must be submitted via R4BP 3 and the
decision on recognition will take approximately five months after authorization has been granted in the reference EU mem-
ber state. If recognition is not agreed upon, the case will be referred to the Commission and if the Commission cannot agree
the case will be referred to ECHA.
Union authorization
Union authorization can be granted to certain substances which have similar conditions of use across the EU. Though there
are exclusion criteria for the products (also, product-types 14, 15, 17, 20, and 21 are excluded), the products granted Union
authorization, do not have to seek EU member state recognition. If a product has both new and existing active substances,
it can currently be registered for EU authorization. If, however, it only has existing substances its authorization time de-
pends on the product-type. Product-types 1, 3, 4, 5, 18 and 19 can be registered from September 1st 2013 while product-
types 2, 6 and 13 can begin registration from January 1st 2017. Product-types 7, 8, 9, 10, 11, 12, 16 and 22 can only register
for Union authorization after January 1st 2020.
Simplified authorization
If the biocidal product‘s active substances are all in Annex I and comply with specified restrictions and if the biocidal pro-
duct does not contain SVHCs or nanomaterials, if its handling and use doesn‘t require personal protective equipment, and
is sufficiently efficient, it can apply for simplified authorization as it is not a very harmful biocide that requires much regula-
tion. To gain authorization, the company must submit its application to an EU member state via R4BP 3. Once the authori-
zation is granted, the company does not have to apply for mutual recognition prior to putting its product on other EU
member states markets. However, it must notify each EU member state 30 days before entering the EU market via R4BP3.
Renewal
For renewal of authorization and recognition, applications must be sent to all EU member states (involved 550 days before
expiry of authorization and recognition. In the case that the company has forgotten to apply for renewal, the company has
180 days to remove its product from the market.
Nanomaterials
Nanomaterials are defined by ECHA as
materials in which 50% or more of the
particles are 1-100nm in at least one
direction. They can be present as free,
unbound particles as well as in aggrega-
tes and agglomerates.
In biocidal products, the presence of
nanomaterials must be made clear
„nano“ in brackets present in the dossier
materials list.
All products containing nanomaterials
are excluded from the simplified authori-
zation procedure and authorization of
products with nanomaterials will last 5
years.
(regardless of whether or not the nano-
material is an active substance or not). It
is important to note that, unless explicitly
stated, the nanoform of a active substance
is not approved. A seperate dossier must
then be prepared for most nanomaterials.
In a biocidal product, all nanomaterials
must have the material name followed by
For in situ biocides, the active sub-
stances created during the process as
well as the associated precursors will
be considered prior to the acceptance
of the biocide on the market. As
such, the precursors and the resulting
active substance must all apply for
registration as separate substances
(which then have to be registered all
together within the resulting biocidal
product noting that the active sub-
stance is in situ). The precursors may
not need to be registered in the case
that the active substance is produced
from their mixture yet they are chemi-
cally stable.
In situ Biocides
The resulting registered in situ biocides
(including releasing substances as well as
the active substance released) will be placed
into Article 95 to provide a centralized da-
tabase.
In situ biocidal product regulation lasts up
to 10 years for the active substance regis-
tered.
 IUCLID Manual for
Biocides
 CLP Manual for
Biocides
Other Guides
BioCity Leipzig
Deutscher Platz 5
D-04103 Leipzig
ACA-Pharma Concept GmbH
Telefon: +49 341 33 73 33 60
Fax: +49 341 33 73 33 69
E-Mail: aca24@aca-pharma.de
Useful Links
ACA-Pharma Concept GmbH/Biocides
[http://aca-pharma.de/chemicals-biocides/]
ECHA/Biocidal Products Regulation
[http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02012R0528-
20140425&from=EN]
ECHA/Application of CLP regulation
[http://echa.europa.eu/documents/10162/13562/clp_en.pdf]
ECHA/Data sharing
[http://echa.europa.eu/documents/10162/13631/guidance_on_data_sharing_en.pdf]

More Related Content

What's hot

Global regulatory guidelines nutraceuticals
Global regulatory guidelines  nutraceuticalsGlobal regulatory guidelines  nutraceuticals
Global regulatory guidelines nutraceuticalsMythili Srinivasan
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in indiaARAVIND R
 
EU Food Regulation on Additives, Novel Foods and Food Contact Materials
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsEU Food Regulation on Additives, Novel Foods and Food Contact Materials
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsDaniele Pisanello
 
Ministry of health labour and welfare (mhlw)
Ministry of health labour and welfare (mhlw)Ministry of health labour and welfare (mhlw)
Ministry of health labour and welfare (mhlw)MUGDHAANAVATTI
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japanManish kumar
 
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
Dr.Lavanya-  Laws pertaining to Ayurvedic drugsDr.Lavanya-  Laws pertaining to Ayurvedic drugs
Dr.Lavanya- Laws pertaining to Ayurvedic drugsDr.Lavanya .S.A
 
Marketing authorization procedures in eu
Marketing authorization procedures in euMarketing authorization procedures in eu
Marketing authorization procedures in euRajaniKarpur
 
Regulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical AnalysisRegulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical AnalysisDr Duggirala Mahendra
 
Biocides - obligations and novelties
Biocides - obligations and noveltiesBiocides - obligations and novelties
Biocides - obligations and noveltiesUrskaPoje
 
Regulatory requirements for herbal medicines
Regulatory requirements for herbal medicinesRegulatory requirements for herbal medicines
Regulatory requirements for herbal medicinesDr-Jitendra Patel
 
Introduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesIntroduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesDoaa Abouzeid
 
Data requirements for vet products
Data requirements for vet productsData requirements for vet products
Data requirements for vet productsMina Adly
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGAAshwiniBawankule
 

What's hot (20)

Schedule t
Schedule tSchedule t
Schedule t
 
Global regulatory guidelines nutraceuticals
Global regulatory guidelines  nutraceuticalsGlobal regulatory guidelines  nutraceuticals
Global regulatory guidelines nutraceuticals
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in india
 
Regulatory issue in india for asu drugs
Regulatory issue in india for asu drugsRegulatory issue in india for asu drugs
Regulatory issue in india for asu drugs
 
EU Food Regulation on Additives, Novel Foods and Food Contact Materials
EU Food Regulation on Additives, Novel Foods and Food Contact MaterialsEU Food Regulation on Additives, Novel Foods and Food Contact Materials
EU Food Regulation on Additives, Novel Foods and Food Contact Materials
 
Ministry of health labour and welfare (mhlw)
Ministry of health labour and welfare (mhlw)Ministry of health labour and welfare (mhlw)
Ministry of health labour and welfare (mhlw)
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
Dr.Lavanya-  Laws pertaining to Ayurvedic drugsDr.Lavanya-  Laws pertaining to Ayurvedic drugs
Dr.Lavanya- Laws pertaining to Ayurvedic drugs
 
Marketing authorization procedures in eu
Marketing authorization procedures in euMarketing authorization procedures in eu
Marketing authorization procedures in eu
 
Regulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical AnalysisRegulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical Analysis
 
Biocides - obligations and novelties
Biocides - obligations and noveltiesBiocides - obligations and novelties
Biocides - obligations and novelties
 
Emea
EmeaEmea
Emea
 
Schedule c
Schedule cSchedule c
Schedule c
 
Regulatory requirements for herbal medicines
Regulatory requirements for herbal medicinesRegulatory requirements for herbal medicines
Regulatory requirements for herbal medicines
 
Introduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesIntroduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agencies
 
Data requirements for vet products
Data requirements for vet productsData requirements for vet products
Data requirements for vet products
 
US FDA
US FDA US FDA
US FDA
 
Regulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGARegulatory requirement of EU, MHRA & TGA
Regulatory requirement of EU, MHRA & TGA
 
Herbal drug regulations
Herbal drug regulationsHerbal drug regulations
Herbal drug regulations
 

Viewers also liked

Prestação de Contas - NISP - 2014/2015
Prestação de Contas - NISP - 2014/2015Prestação de Contas - NISP - 2014/2015
Prestação de Contas - NISP - 2014/2015Daniel Pinheiro
 
BDC-presentation
BDC-presentationBDC-presentation
BDC-presentationPavel Popa
 
Presentación PLE, M.Personal e ID
Presentación PLE, M.Personal e IDPresentación PLE, M.Personal e ID
Presentación PLE, M.Personal e IDLuis Corró
 
100% 30 pages
100% 30 pages100% 30 pages
100% 30 pagesmediahta
 
YOUR VANCOUVER PLUMBER
YOUR VANCOUVER PLUMBERYOUR VANCOUVER PLUMBER
YOUR VANCOUVER PLUMBERamit kumar
 
Magnus Technical News Letter Nov-2016
Magnus Technical News Letter Nov-2016Magnus Technical News Letter Nov-2016
Magnus Technical News Letter Nov-2016Aravind K
 
Ten German Lessons for Canadian Energy Policy
Ten German Lessons for Canadian Energy PolicyTen German Lessons for Canadian Energy Policy
Ten German Lessons for Canadian Energy PolicyMichael Clarke
 
Sales and Distribution Management of Bayer Crop Science Limited
Sales and Distribution Management of Bayer Crop Science Limited Sales and Distribution Management of Bayer Crop Science Limited
Sales and Distribution Management of Bayer Crop Science Limited Dr. Asokendu Samanta
 
Pesticide industry
Pesticide industryPesticide industry
Pesticide industryChandan Puri
 

Viewers also liked (15)

Prestação de Contas - NISP - 2014/2015
Prestação de Contas - NISP - 2014/2015Prestação de Contas - NISP - 2014/2015
Prestação de Contas - NISP - 2014/2015
 
2plan_Edition16_Newsletter
2plan_Edition16_Newsletter2plan_Edition16_Newsletter
2plan_Edition16_Newsletter
 
BDC-presentation
BDC-presentationBDC-presentation
BDC-presentation
 
Presentación PLE, M.Personal e ID
Presentación PLE, M.Personal e IDPresentación PLE, M.Personal e ID
Presentación PLE, M.Personal e ID
 
100% 30 pages
100% 30 pages100% 30 pages
100% 30 pages
 
YOUR VANCOUVER PLUMBER
YOUR VANCOUVER PLUMBERYOUR VANCOUVER PLUMBER
YOUR VANCOUVER PLUMBER
 
Magnus Technical News Letter Nov-2016
Magnus Technical News Letter Nov-2016Magnus Technical News Letter Nov-2016
Magnus Technical News Letter Nov-2016
 
Jozhus Book
Jozhus BookJozhus Book
Jozhus Book
 
Ten German Lessons for Canadian Energy Policy
Ten German Lessons for Canadian Energy PolicyTen German Lessons for Canadian Energy Policy
Ten German Lessons for Canadian Energy Policy
 
נגישות אתרים
נגישות אתריםנגישות אתרים
נגישות אתרים
 
Pesticide industry
Pesticide industryPesticide industry
Pesticide industry
 
Pesticide Industry
Pesticide IndustryPesticide Industry
Pesticide Industry
 
Sales and Distribution Management of Bayer Crop Science Limited
Sales and Distribution Management of Bayer Crop Science Limited Sales and Distribution Management of Bayer Crop Science Limited
Sales and Distribution Management of Bayer Crop Science Limited
 
Pesticide Industry
Pesticide IndustryPesticide Industry
Pesticide Industry
 
Pesticide industry
Pesticide industryPesticide industry
Pesticide industry
 

Similar to General Biocides Booklet

Combination Products
Combination ProductsCombination Products
Combination Productschemist874
 
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...Mohamed Fazil M
 
Ppt indo-eng-converted
Ppt indo-eng-convertedPpt indo-eng-converted
Ppt indo-eng-convertedbangsandy1
 
Canadian policy for combination (drug / device) products
Canadian policy for combination (drug / device) productsCanadian policy for combination (drug / device) products
Canadian policy for combination (drug / device) productsJasmin NUHIC
 
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Holly Groelle
 
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesThe Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesEuropean Industrial Pharmacists Group
 
Good clinical practices tutorial-june-21-09 shehnaz-v7.0
Good clinical practices tutorial-june-21-09 shehnaz-v7.0Good clinical practices tutorial-june-21-09 shehnaz-v7.0
Good clinical practices tutorial-june-21-09 shehnaz-v7.0Shehnaz Vakharia
 
Drug approval in US, EU & India
Drug approval in US, EU & IndiaDrug approval in US, EU & India
Drug approval in US, EU & IndiaSweta Yadav
 
Regulatory requirements for the product
Regulatory requirements for the productRegulatory requirements for the product
Regulatory requirements for the productAshutoshPanday5
 
(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelinesDishant shah
 

Similar to General Biocides Booklet (20)

Combination Products
Combination ProductsCombination Products
Combination Products
 
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
CDSCO Biologicals - Rules, Regulations, Guidelines and Standards for Regulato...
 
Ppt indo-eng-converted
Ppt indo-eng-convertedPpt indo-eng-converted
Ppt indo-eng-converted
 
Canadian policy for combination (drug / device) products
Canadian policy for combination (drug / device) productsCanadian policy for combination (drug / device) products
Canadian policy for combination (drug / device) products
 
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid ...
 
Circular 12/VBHN-BYT: Prescribing Management of Functional Foods
Circular 12/VBHN-BYT: Prescribing Management of Functional FoodsCircular 12/VBHN-BYT: Prescribing Management of Functional Foods
Circular 12/VBHN-BYT: Prescribing Management of Functional Foods
 
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITYCircular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
Circular 11/2018/TT-BYT: ON DRUG/DRUG INGREDIENT QUALITY
 
Circular 08/2022/TT-BYT: MARKETING AUTHORIZATION OF DRUGS AND MEDICINAL MATER...
Circular 08/2022/TT-BYT: MARKETING AUTHORIZATION OF DRUGS AND MEDICINAL MATER...Circular 08/2022/TT-BYT: MARKETING AUTHORIZATION OF DRUGS AND MEDICINAL MATER...
Circular 08/2022/TT-BYT: MARKETING AUTHORIZATION OF DRUGS AND MEDICINAL MATER...
 
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
Groelle_GlobalRegulatoryConsiderationsBiosimilars_13Jun14
 
Circular 43/2014/TT-BYT: REGULATING THE MANAGEMENT OF FUNCTIONAL FOODS
Circular 43/2014/TT-BYT: REGULATING THE MANAGEMENT OF FUNCTIONAL FOODSCircular 43/2014/TT-BYT: REGULATING THE MANAGEMENT OF FUNCTIONAL FOODS
Circular 43/2014/TT-BYT: REGULATING THE MANAGEMENT OF FUNCTIONAL FOODS
 
The Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified MedicinesThe Implications of Implementing the Directive on Falsified Medicines
The Implications of Implementing the Directive on Falsified Medicines
 
Good clinical practices tutorial-june-21-09 shehnaz-v7.0
Good clinical practices tutorial-june-21-09 shehnaz-v7.0Good clinical practices tutorial-june-21-09 shehnaz-v7.0
Good clinical practices tutorial-june-21-09 shehnaz-v7.0
 
Drug Control and Registration in Thailand - 2010
Drug Control and Registration in Thailand - 2010Drug Control and Registration in Thailand - 2010
Drug Control and Registration in Thailand - 2010
 
ANDA, IMPD & IB
ANDA, IMPD & IBANDA, IMPD & IB
ANDA, IMPD & IB
 
Drug Registration Thailand_2010
Drug Registration Thailand_2010Drug Registration Thailand_2010
Drug Registration Thailand_2010
 
Drug approval in US, EU & India
Drug approval in US, EU & IndiaDrug approval in US, EU & India
Drug approval in US, EU & India
 
Circular 03/2020/TT-BYT: AMENDMENTS TO SOME ARTICLES OF THE CIRCULAR NO. 11/2...
Circular 03/2020/TT-BYT: AMENDMENTS TO SOME ARTICLES OF THE CIRCULAR NO. 11/2...Circular 03/2020/TT-BYT: AMENDMENTS TO SOME ARTICLES OF THE CIRCULAR NO. 11/2...
Circular 03/2020/TT-BYT: AMENDMENTS TO SOME ARTICLES OF THE CIRCULAR NO. 11/2...
 
Decree 15/2018/ND-CP: ELABORATION OF SOME ARTICLES OF THE LAW OF FOOD SAFETY
Decree 15/2018/ND-CP: ELABORATION OF SOME ARTICLES OF THE LAW OF FOOD SAFETYDecree 15/2018/ND-CP: ELABORATION OF SOME ARTICLES OF THE LAW OF FOOD SAFETY
Decree 15/2018/ND-CP: ELABORATION OF SOME ARTICLES OF THE LAW OF FOOD SAFETY
 
Regulatory requirements for the product
Regulatory requirements for the productRegulatory requirements for the product
Regulatory requirements for the product
 
(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines(15 mph104) cdsco & fda guidelines
(15 mph104) cdsco & fda guidelines
 

General Biocides Booklet

  • 1. The Biocidal Product Regula- tion (BPR, Regulation (EU) 528/2012) came into force on 1 September 2013 (repealing the Biocidal Products Directi- ve (Directive 98/8/EC)). The BPR concerns the placment and use of biocidal products on the market, which are used to protect humans, animals, materials or articles against harmful organisms, like pests or bacteria through active substances within the biocidal product. In general, all biocidal pro- ducts require authorization before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved. How- ever, there are certain excepti- ons and transitional periods for certain provisions. For example, active substances in the Review Programme (where the final decision on approval is still pending) can be made available on the mar- ket as ingredient in biocidal products. Products contai- ning new active substances that are still under assessment may also be allowed on the market if provisional authori- sation is granted. Applications for active sub- stances or biocidal products are done on the IT tool IU- CLID 5 (International Uni- form Chemical Information Database). The application dossiers will be submitted to ECHA via the IT platform R4BP 3 (Register for Biocidal Products). This tool is also used to exchange data and information between the ap- plicant, ECHA, Member State competent authorities and the European Commission which grant authorization. This guide is meant to intro- duce the interested party to the processes involved in a biocidal product application. It is important to note that biocidal products typically takes at least two years to fully authorize as there are two steps primary involved (the authorization of the active substances in the product then the authorization of the biocidal product). With the current EU policy requiring all biocides to be registered by September 2015, now is the time to begin the application process in order to complete- ly and correctly submit your application. If your applica- tion is not submitted in time, the biocidal product will have to be pulled from the market regardless of whether it is safe or not. MAY 2015 Introduction Version 1.0 GeneralGuideforBiocidalAuthorization ACA-PHARMACONCEPTGMBH Biocide Definition Introduction 1 Biocide Definition 1 Active Substance 2 Application Timeline 2 Special Deadlines 2 List of Abreviations 3 SME Status 3 Product Types 4 Authorization Types 5 Nanomaterials 5 In situ Biocides 5 List of Other Guides 6 Useful Links 6 Contact Information 6 Table of Contents According to Article 3 of BPR, a biocide is any substance or mixture, in the form in which it is supplied to the user, con- sisting of, containing or gene- rating one or more active sub- stances, with the intention of destroying, deterring, ren- dering harmless, preventing the action of, or otherwise exerting a controlling effect on any harmful organism by any means other than mere physi- cal or mechanical action as well as any substance or mix- ture, generated from sub- stances or mixtures which do not themselves fall under the first definition, to be used with the intention of destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a control- ling effect on, any harmful organism by any means other than mere physical or mechanical action. Often biocides are used to protect economic products that could be damaged or destroyed by a harmful orga- nism. This includes argicul- tural products including food and lumber as well as animals. Generally speaking, biocides under this definiti- on are either pesticides (including herbicides, insceticides, and rodentici- des among others) or anti- microbials (including antibi- otics, antifugals, and antipa- rasites among others) or both. It is important to no- te, however, that a product will only be considered a biocide if its action does not fall into the list of regulati- ons in Article 2 of BPR which includes biocides that are present in feed, medica- ted feedstuffs,veterinary medicines,human medicines, flavourings and ingredients with flavouring properties, plant protection products, toys, cosmetics, or biocides used as processing aids.
  • 2. by ECHA before entering the market. In situ biocides must submit their dossiers which include the suppliers of the precur- sors as well as information on the biocide produced to ECHA for evaluation by the 1st of September 2015. Articles treated with biocides must have submitted their applications by the 1st of September 2016 unless it contains ative substances that have not been yet recogn- zed by ECHA in which case it has until March 1st 2017. Biocidal products with SVHCs/candidates for substitution as active substances or non-active components must be regis- tered by September 1st 2015 and since ECHA is attempting to replace SVHCs, these products cannot be authorized for more than five years. Seite 2 GENERAL GUIDE FOR BIOCIDAL AUTHORIZATION Application Timeline Submission of Application Validation For substances currently on the market, submissi- on must occur by the: 1st of September 2015 Fee payment Requested information BPC decision 30 30 90 365 270 days Comments on draft 30Dossier evaluation Committee decision for authorization The time for authorization of a biocidal product is approximately two years. The time required for a dossier evaluation and BPC decision are approximate. The time required for the final committee decision on authorization is highly variable. Also, should additional information be requested during the dossier evaluation, an additional 180 days may be given to provide the necessary data. Biocidal authorization can be granted for up to 10 years. If the biocidal pro- duct contains a substance that is up for substitution, the biocidal product can- not get granted authorization for more than 5 years. If the substance in question is already under the jurisdiction of a previous biocidal regulation, it does not have to follow current ECHA biocidal regulati- ons. Materials which wish to enter the European market must be approved Special Deadlines Additional information 180 EU authorization Before any biocidal product is approved by ECHA, the active substances that are part of a biocidal function must be ap- proved and authorized for use in the EU through ECHA. The first step to do this is to submit a IUCLID active substance portfolio to a member state‘s competenet authority via R4BP3. After the member state has evaluated the substance, ECHA‘s biocidal comittee will also decide on the status of the active substance in question within 270 days. [For further information on how to use and submit the required informa- tion to ECHA for approval, please see ACA-Pharma Concept‘s IUCLID guide to Biocides] These opinions serve as the basis for the decision on approval which is then adopted by the European Commission. Gai- ning approval for the active substance can take well over a year, so it is important to start the approval process as soon as possible. Once approval has been granted, an active substance‘s approval can be granted for up to 10 years and is rewable. In principle, active substances meeting the exclusion criteria defined in the BPR will not be approved. However, sub- stances of very high concern, such as those that are carcinogenic, mutagenic and reprotoxic substances in categories 1A or 1B in CLP Regulation, endocrine disruptors, and substances which are persistent bioaccumulative and toxic (PBT) or are very persistent and very bioacumulative (vPvB) will not be approved unless there are no alternatives available. If the substance of high concern is indeed the only option, it can only be approved for up to five years and is subject to evaulati- on in the case of a better, safer substitute. Biocidal Products Committee opinions on active substance approval can be viewed on ECHA Homepage. European Commission includes approved active substances in the Union list of approved active substances (formerly Annex I of Directive 98/8/EC). Companies wishing to get an authorisation for a biocidal product can consult this list to identify ac- tive substances for use in biocidal products and treated articles. A consolidated list of existing active substances for which a decision of non-inclusion into Annex I or IA of Directive 98/8/EC has been adopted is also available. Biocidal products containing active substances for which a non-inclusion decision was taken shall be removed from the market within 12 months of the entering into force of such decision; unless otherwise stipulated in that non-inclusion decision. Active Substance Authorization
  • 3. List of Abbreviations Abbreviation Complete name Explanation BPC Biocidal product committee The committe under ECHA which ultimately decides the fate of a dossier‘s applicaiton (whether or not is should be authorized) BPR Biocidal product regiulation Regulation EC 528/2012 that governs the use, productions, and distribution of biocides in the EU which companies are obligated to follow CLP Classification, labelling and packaging regulation Regulation EC 1272/2008 that harmonizes the criteria for classification and the rules on label- ling and packaging harardous goods and mixtures ECHA European Chemicals Agency Regulatory authority on chemical safety which is also responsible for the impelentation of EU chemical regulations EU European Union International governing body which allows for trade and economic regualtions to be the same throughout member states IUCLID International Uniform Chemical Information Database IT tool used for data submission, evaluation and exchange PBT Persistent bioaccumulative and toxic A variety of toxic chemicals that exhibit persistent bioacculumative properties that are consi- dered SVHCs by ECHA REACH Registration, evaluation, authorization , and restriction of chemicals Regulation EG 1907/2006 which stipulates the registration, evaluation, authorization, and restriction processes and rules for chemicals in the EU SME Micro-, small, and medium-sized enter- prises Enterprises that are defined according to their staff head count and turnover or annual balan- ce-sheet total. Thez can recieve discounted fees and charges during ECHA registration once their SME status is confirmed SVHC Substance of very high concern Substances meeting the criteria for classification as carcinogenic, mutagenic or toxic for repro- duction category 1A or 1B or which are PBT or vPvB or giving rise to an equivalent level of concern. They may need to be authorised for specific uses but must follow stricter guidelines as approved by ECHA vPvB Very persistent and very bioaccumulati- ve A variety of chemicals that are very bioacculumative and persist in the environment for pro- longed periods of time that are considered SVHCs by ECHA Seite 3MAY 2015 SME Status SMEs (micro-,small, and medium enter- prises) are elligible for reduced fees and charges during ECHA registration. As such, SME registration is highly moni- tored and mistakes within the applicati- on for SME status can result in steep fine and charges. The information needed to prove SME status is simple: staff head count and annual turnover/balance sheet totals. Of these two factors, staff head count is the more important of the two and will often decide the exact status of the enterprise. Staff, in this case, applies to employees (actual or recognized as usch under national law), owner-managers, persons working for the enterprise and being subordinated to it, as well as part- ners who are engaged in the company and recieve financial benefits from it. It does not include apprentices or students enga- ged in vocational training. Maternity and paternity leaves are also not included. Microenterprises should have a staff of less than 10 individuals. Small enterprises should have less than 50 staf members while medium enterprises should have less than 250. If the staff number falls below a threshold, the annual turnover/annual balanace sheet total for the past two years will be used to determine placement. Microenterprises should have an annual turnover less than 2 million euros while a small enterprise and a medium enterprise should have annual turnovers of less than 10 million euros and 43 million euros respectively. It is important to note that if the enter- prise in question is not autonomous (fully independent or lesss than 25% of its ca- pital or holding rights are held by outside investors) all of its linked or partner enterprises must be included in the deter- mination of SME status.
  • 4. Seite 4 GENERAL GUIDE FOR BIOCIDAL AUTHORIZATION Product Types Main Group Type number Product-type Description Disinfectants 1 Human hygiene products Skin or scalp disinfectants Disinfectants 2 Disinfectants/algaecides not for dirrect applications to humans or animals Surface disinfectants, water disinfecants that are not intended for animal or human ingestion, air disiinfectants, and other products with disinfecting properties... Disinfectants 3 Veterinary hygiene Surface disinfectants and anti-microbials for the housing of animals... Disinfectants 4 Food and feed area Disinfectants for equipment, containers, utensils, surfaces, or pipework associated with production, storage, transport, or consumption of food and feed including water Disinfectants 5 Drinking water disinfectants For animals and human use Preservatives 6 Preservatives for products during storage Preservation of manufactured products other than foodtuffs, feedingstuffs, cometics, or medical products and storage or use of rodenticide, insecticide, or other baits Preservatives 7 Film preservatives Preservation of paints, plastics, selanats, sealants, binders, papers, art work, and wall adhesives Preservatives 8 Wood preservatives Preventative and curative products from and including the saw-mill stage Preservatives 9 Fiber, leather, rubber, and polymerized material preservatives Materials which prevent microbial settling and deterioration Preservatives 10 Construction material preservatives Preservation of masonry, composiste materials and other non-wood materials Preservatives 11 Preservatives for liquid-cooling an dprocessing systems Preservation of water and other liquids by controlling organisms Preservatives 12 Slimicides Prevention/control of slime on materials, equipment and structures in industrial pro- cesses Preservatives 13 Working or cutting fluid preservatives Control microbial deteioration in fluids used for working or cutting metals, glass, or other materials Pesticides 14 Rodenticides By means other than repulsion or attraction Pesticides 15 Avicides By means other than repulsion or attraction Pesticides 16 Molluscicides vermicides, and products used to control other invertebrates By means other than repulsion or attraction Pesticides 17 Piscicides By means other than repulsion or attraction Pesticides 18 Insceticides, acaracides, and products to control other arthropods By means other than repulsion or attraction Pesticides 19 Repellents and attractants By repelling or attracting harmful organisms (including fleas, vertebrates such as birds, fish and rodents) in question on a surface or on human or animal skin Pesticides 20 Control of other vertebrates Other methods of control other than attraction or repulsion of vertebrates other than those before Other Biocidal Product 21 Antifouling products Limit the settling of microbes and higher organisms on vessels, aquaculture or other structures in water Other Biocidal Product 22 Embalming or taxidermist fluids Disinfection and preservation of human and animal corpses
  • 5. Authorization Types Seite 5MAY 2015 ECHA provides several kinds of authorization types for biocidal products The determination of which authorization is given de- pends on the product in question as well as the markets(s) in which the company wants to sell its product in. National authorization National authorization is for companies that want their product to be authorized in one EU member state. The application must be submitted via R4BP 3. The member state‘s competent authority will then process the authorization request analyze and compare the substance to other substances which may be less harmful, and make a decision on authorization within 365 days. Mutual recognition Mutual recognition is national authorization that has been recognized beyong the frist/reference country of application and is done when a company requests other EU member states to recognize ist product.This can be done in parallel or sequen- tially with its application to the reference EU member state. Either way, the dossier must be submitted via R4BP 3 and the decision on recognition will take approximately five months after authorization has been granted in the reference EU mem- ber state. If recognition is not agreed upon, the case will be referred to the Commission and if the Commission cannot agree the case will be referred to ECHA. Union authorization Union authorization can be granted to certain substances which have similar conditions of use across the EU. Though there are exclusion criteria for the products (also, product-types 14, 15, 17, 20, and 21 are excluded), the products granted Union authorization, do not have to seek EU member state recognition. If a product has both new and existing active substances, it can currently be registered for EU authorization. If, however, it only has existing substances its authorization time de- pends on the product-type. Product-types 1, 3, 4, 5, 18 and 19 can be registered from September 1st 2013 while product- types 2, 6 and 13 can begin registration from January 1st 2017. Product-types 7, 8, 9, 10, 11, 12, 16 and 22 can only register for Union authorization after January 1st 2020. Simplified authorization If the biocidal product‘s active substances are all in Annex I and comply with specified restrictions and if the biocidal pro- duct does not contain SVHCs or nanomaterials, if its handling and use doesn‘t require personal protective equipment, and is sufficiently efficient, it can apply for simplified authorization as it is not a very harmful biocide that requires much regula- tion. To gain authorization, the company must submit its application to an EU member state via R4BP 3. Once the authori- zation is granted, the company does not have to apply for mutual recognition prior to putting its product on other EU member states markets. However, it must notify each EU member state 30 days before entering the EU market via R4BP3. Renewal For renewal of authorization and recognition, applications must be sent to all EU member states (involved 550 days before expiry of authorization and recognition. In the case that the company has forgotten to apply for renewal, the company has 180 days to remove its product from the market. Nanomaterials Nanomaterials are defined by ECHA as materials in which 50% or more of the particles are 1-100nm in at least one direction. They can be present as free, unbound particles as well as in aggrega- tes and agglomerates. In biocidal products, the presence of nanomaterials must be made clear „nano“ in brackets present in the dossier materials list. All products containing nanomaterials are excluded from the simplified authori- zation procedure and authorization of products with nanomaterials will last 5 years. (regardless of whether or not the nano- material is an active substance or not). It is important to note that, unless explicitly stated, the nanoform of a active substance is not approved. A seperate dossier must then be prepared for most nanomaterials. In a biocidal product, all nanomaterials must have the material name followed by For in situ biocides, the active sub- stances created during the process as well as the associated precursors will be considered prior to the acceptance of the biocide on the market. As such, the precursors and the resulting active substance must all apply for registration as separate substances (which then have to be registered all together within the resulting biocidal product noting that the active sub- stance is in situ). The precursors may not need to be registered in the case that the active substance is produced from their mixture yet they are chemi- cally stable. In situ Biocides The resulting registered in situ biocides (including releasing substances as well as the active substance released) will be placed into Article 95 to provide a centralized da- tabase. In situ biocidal product regulation lasts up to 10 years for the active substance regis- tered.
  • 6.  IUCLID Manual for Biocides  CLP Manual for Biocides Other Guides BioCity Leipzig Deutscher Platz 5 D-04103 Leipzig ACA-Pharma Concept GmbH Telefon: +49 341 33 73 33 60 Fax: +49 341 33 73 33 69 E-Mail: aca24@aca-pharma.de Useful Links ACA-Pharma Concept GmbH/Biocides [http://aca-pharma.de/chemicals-biocides/] ECHA/Biocidal Products Regulation [http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02012R0528- 20140425&from=EN] ECHA/Application of CLP regulation [http://echa.europa.eu/documents/10162/13562/clp_en.pdf] ECHA/Data sharing [http://echa.europa.eu/documents/10162/13631/guidance_on_data_sharing_en.pdf]